Biomea Fusion, Inc. (BMEA) stock
BMEANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.56−0.05 (-7.89%)
Close on Nov 12, 2026Market cap $40.79MP/E –Yield –
Biomea Fusion net income
Net income is the profit left for shareholders after every expense, interest and tax.
Biomea Fusion's net income for the twelve months ending Sep 30, 2026 was -$22.31M. For fiscal 2025 it was -$61.80M. The highest annual figure on record is -$1.20M in fiscal 2019.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$61.80M | – |
| FY2024 | Dec 31, 2024 | -$138.43M | – |
| FY2023 | Dec 31, 2023 | -$117.26M | – |
| FY2022 | Dec 31, 2022 | -$81.83M | – |
| FY2021 | Dec 31, 2021 | -$41.57M | – |
| FY2020 | Dec 31, 2020 | -$5.32M | – |
| FY2019 | Dec 31, 2019 | -$1.20M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$6.18M | – |
| Q2 FY2026 | Jun 30, 2026 | -$8.33M | – |
| Q1 FY2026 | Mar 31, 2026 | -$12.42M | – |
| Q4 FY2025 | Dec 31, 2025 | $4.61M | – |
| Q3 FY2025 | Sep 30, 2025 | -$16.41M | – |
| Q2 FY2025 | Jun 30, 2025 | -$20.74M | – |
| Q1 FY2025 | Mar 31, 2025 | -$29.26M | – |
| Q4 FY2024 | Dec 31, 2024 | -$29.30M | – |
| Q3 FY2024 | Sep 30, 2024 | -$32.79M | – |
| Q2 FY2024 | Jun 30, 2024 | -$37.28M | – |
| Q1 FY2024 | Mar 31, 2024 | -$39.06M | – |
| Q4 FY2023 | Dec 31, 2023 | -$34.88M | – |
| Q3 FY2023 | Sep 30, 2023 | -$28.43M | – |
| Q2 FY2023 | Jun 30, 2023 | -$24.89M | – |
| Q1 FY2023 | Mar 31, 2023 | -$29.05M | – |
| Q4 FY2022 | Dec 31, 2022 | -$25.31M | – |
| Q3 FY2022 | Sep 30, 2022 | -$22.89M | – |
| Q2 FY2022 | Jun 30, 2022 | -$17.26M | – |
| Q1 FY2022 | Mar 31, 2022 | -$16.37M | – |
| Q4 FY2021 | Dec 31, 2021 | -$14.71M | – |
| Q3 FY2021 | Sep 30, 2021 | -$12.61M | – |
| Q2 FY2021 | Jun 30, 2021 | -$8.40M | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.85M | – |
| Q4 FY2020 | Dec 31, 2020 | -$3.50M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.14M | – |
| Q2 FY2020 | Jun 30, 2020 | -$293.00K | – |
| Q1 FY2020 | Mar 31, 2020 | -$398.00K | – |
See a number that looks wrong?